These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Molecular theory about the mechanism of action of curare compounds]. Waser PG. Anaesthesist; 1971 Jan; 20(1):23-9. PubMed ID: 4251063 [No Abstract] [Full Text] [Related]
3. Antagonism of tubocurarine. III. Time course of action of pyridostigmin, neostigmine, and edrophonium in vivo and in vitro. SMITH CM, MEAD JC, UNNA KR. J Pharmacol Exp Ther; 1957 Jun; 120(2):215-28. PubMed ID: 13463743 [No Abstract] [Full Text] [Related]
4. [On the pharmacology of curarizing substances and their antagonists]. DE VLEESCHHOUWER GR. Belg Tijdschr Geneesk; 1961 Jun 15; 17():601-28. PubMed ID: 13720928 [No Abstract] [Full Text] [Related]
12. Use of pyridostigmine for the reversal of neuromuscular blockade. McNall PG, Wolfson B, Tuazon JG, Siker ES. Anesth Analg; 1969 Jul 15; 48(6):1026-32. PubMed ID: 5391379 [No Abstract] [Full Text] [Related]
13. Neostigmine accelerates recovery from moderate mivacurium neuromuscular block independently of train-of-four count at injection: a randomised controlled trial. Nicolardot J, Engelman E, Coeckelenbergh S, Jungels C, Baurain M. Br J Anaesth; 2018 Aug 15; 121(2):497-499. PubMed ID: 30032892 [No Abstract] [Full Text] [Related]
14. A case of apparent re-dosing of atracurium during neostigmine reversal in a dog. De Carellan AG, Pelligand L. Vet Anaesth Analg; 2013 May 15; 40(3):334-6. PubMed ID: 23331619 [No Abstract] [Full Text] [Related]